Rethinking Youth Gender Medicine with Dr Louise Irvine
Dr Louise Irvine, a UK GP and Co-Chair of the Clinical Advisory Network on Sex and Gender, joins the Beyond Gender hosts to preview CAN-SG's London conference on youth gender medicine. From the WellBN investigation to NHS institutional capture, the conversation is essential listening for anyone tracking how Britain's healthcare system arrived at this moment — and what a clinically grounded path forward might look like.
Dr Louise Irvine brings a distinctly British clinical perspective to the conversation. As a GP, GP trainer and Co-Chair of the Clinical Advisory Network on Sex and Gender — known as CAN-SG — she has been at the forefront of efforts to ensure that medical practice on gender in the UK is guided by evidence, ethics and patient welfare rather than ideology. Her appearance coincides with CAN-SG's forthcoming conference in London, Rethinking Youth Gender Medicine, scheduled for the fifth and sixth of July, which promises to draw together clinicians, researchers and policymakers for a forensic examination of where things went wrong. The conversation begins with the conference itself, and what CAN-SG hopes it will achieve. Irvine sets out the breadth of territory the event will cover: aetiology — how and why so many young people came to present with gender distress — alongside questions of research quality, ethical standards, and what good clinical practice should look like going forward. For British listeners who have watched the National Health Service navigate the fallout from the Cass Review and the closure of the Tavistock clinic, this framing will feel particularly urgent. The questions are no longer theoretical; they carry direct consequences for thousands of young people and their families. A significant portion of the discussion is devoted to the WellBN clinic, a recent investigation that has drawn further scrutiny to the provision of gender-related care in Britain. Irvine recaps what happened and what the case reveals about how institutions — including parts of the NHS — became captured by a particular ideological framework. This thread runs through much of the current British debate: how professional bodies, regulators and healthcare providers came to endorse practices that, on clinical examination, lack the evidence base expected of any medical intervention in children. The episode also examines the puberty blocker trial and what properly designed research in this area would actually require. Helen Joyce's concept of tooth fairy science — research that assumes the conclusion before asking the question — is discussed as a way of understanding why so much existing literature has failed to meet basic scientific standards. For anyone trying to make sense of why British institutions took so long to change course, this section alone repays careful attention. New clinical services emerging to replace what Tavistock once provided, the potential for data linkage studies to follow up on young people who received earlier interventions, and the practical question of what good therapeutic care looks like for gender-distressed young people all feature in the closing stages of the conversation. Irvine's contribution is grounded and constructive: the aim is not simply to relitigate the past but to build a clearer clinical picture that can protect the next generation of patients.
